⌘K
Loading ticker…
As of 2026-08-24, Century Therapeutics, Inc. Common Stock (IPSC) has a 3-month relative strength percentile of 36 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 83. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.5%, relative volume 0.65×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
IPSC is in a stage 3 topping pattern, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -2.3% / 12.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
IPSC appears in 1 ETF as of May 2026: AVSC at 0.01% weight, $307K notional.
Held by 7 ETFs · $13M across latest filings · largest weight 0.01% (AVSC).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVSC | 0.01% | $307K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IPSC Jan avg: 22.56% median: 9.00% win: 50% σ: 50.17% n: 4 2022-04-12 → 2026-07-31 | IPSC Feb avg: -2.57% median: -7.78% win: 25% σ: 17.79% n: 4 2022-04-12 → 2026-07-31 | IPSC Mar avg: -10.51% median: -12.82% win: 25% σ: 20.06% n: 4 2022-04-12 → 2026-07-31 | IPSC Apr avg: -3.68% median: 1.33% win: 60% σ: 17.23% n: 5 2022-04-12 → 2026-07-31 | IPSC May avg: -3.82% median: 1.60% win: 60% σ: 13.73% n: 5 2022-04-12 → 2026-07-31 | IPSC Jun avg: -2.55% median: -0.63% win: 20% σ: 7.20% n: 5 2022-04-12 → 2026-07-31 | IPSC Jul avg: -1.95% median: -3.48% win: 20% σ: 16.81% n: 5 2022-04-12 → 2026-07-31 | IPSC Aug avg: -12.61% median: -14.45% win: 0% σ: 9.34% n: 4 2022-04-12 → 2026-07-31 (current) | IPSC Sep avg: -6.73% median: -4.42% win: 25% σ: 8.93% n: 4 2022-04-12 → 2026-07-31 | IPSC Oct avg: -8.25% median: -8.67% win: 50% σ: 23.68% n: 4 2022-04-12 → 2026-07-31 | IPSC Nov avg: 8.16% median: -3.24% win: 25% σ: 27.94% n: 4 2022-04-12 → 2026-07-31 | IPSC Dec avg: 33.09% median: 20.58% win: 50% σ: 94.86% n: 4 2022-04-12 → 2026-07-31 |